Matches in Harvard for { <http://id.lib.harvard.edu/aleph/004027833/catalog> ?p ?o. }
Showing items 1 to 30 of
30
with 100 items per page.
- catalog abstract ""Emphasizing the role of monoamine oxidase (MAO) in the etiology and pathogenesis of Parkinson's disease and Alzheimer's disease, this up-to-date reference describes the genetics, physiology, biochemistry, pharmacology, and clinical aspects of this very important class of enzymes. Details how the interaction between selegiline (deprenyl) and MAO may retard the progression of neurodegenerative disorders! Providing the latest theories on how selegiline operates, Monoamine Oxidase Inhibitors in Neurological Diseases - presents fundamental information on MAO types A and B - examines the distribution of MAO A and B in the normal human brain - investigates the effects of disease and aging on MAO A and B - analyzes a critical role for MAO in the toxic action in Parkinson's disease - elucidates selegiline's novel ability to delay the progression or repair the damage of dopaminergic neurons - discusses the usefulness of MAO inhibitors in psychiatric disease - and more!!"--Publisher description (LoC).".
- catalog contributor b5793743.
- catalog created "c1994.".
- catalog date "1994".
- catalog date "c1994.".
- catalog dateCopyrighted "c1994.".
- catalog description ""Emphasizing the role of monoamine oxidase (MAO) in the etiology and pathogenesis of Parkinson's disease and Alzheimer's disease, this up-to-date reference describes the genetics, physiology, biochemistry, pharmacology, and clinical aspects of this very important class of enzymes. Details how the interaction between selegiline (deprenyl) and MAO may retard the progression of neurodegenerative disorders! Providing the latest theories on how selegiline operates, Monoamine Oxidase Inhibitors in Neurological Diseases - presents fundamental information on MAO types A and B - examines the distribution of MAO A and B in the normal human brain - investigates the effects of disease and aging on MAO A and B - analyzes a critical role for MAO in the toxic action in Parkinson's disease - elucidates selegiline's novel ability to delay the progression or repair the damage of dopaminergic neurons - discusses the usefulness of MAO inhibitors in psychiatric disease - and more!!"--Publisher description (LoC).".
- catalog description "Includes bibliographical references and index.".
- catalog extent "xviii, 371 p. ;".
- catalog identifier "0824790820 (alk. paper)".
- catalog isPartOf "Neurological disease and therapy ; v. 21".
- catalog issued "1994".
- catalog issued "c1994.".
- catalog language "eng".
- catalog publisher "New York : Marce Dekker,".
- catalog subject "616.8 20".
- catalog subject "Monoamine Oxidase Inhibitors therapeutic use.".
- catalog subject "Monoamine Oxidase metabolism.".
- catalog subject "Monoamine oxidase Inhibitors Therapeutic use.".
- catalog subject "Monoamine oxidase.".
- catalog subject "Nervous system Degeneration Chemotherapy.".
- catalog subject "Parkinson Disease drug therapy.".
- catalog subject "Parkinson Disease etiology.".
- catalog subject "Parkinson's disease Chemotherapy.".
- catalog subject "RC365 .M66 1994".
- catalog subject "Selegiline Therapeutic use.".
- catalog subject "Selegiline therapeutic use.".
- catalog subject "W1 NE33LD v. 21 1994 WL 359 M751 1994".
- catalog title "Monoamine oxidase inhibitors in neurological diseases / edited by Abraham Lieberman ... [et al.].".
- catalog type "text".